Medicare does not currently supply reporting for ketamine therapy or infusions to treat mental health conditions .

This is because the Food and Drug Administration ( FDA ) only approve the drug ketamine for habit in general anesthetics .

However , Medicare may cover the drug Spravato , which control esketamine . This is an FDA - approved drug that derive from ketamine and may help treatment - resistant depression .

Medicare coverage for ketamine

Although theFDA has not yet approvedketamine therapy for mental wellness condition , someresearch suggestsit could have significant potency , let in for self-destructive ideation and treatment - resistive depression .

There are two types of ketamine hydrochloride :

R-ketamine

R - Ketalar is FDA okay for utilisation in any anaesthetic agent a person may receive as an intravenous ( IV ) extract or intramuscular injection ( snapshot ) .

Medicare Part A covers anaesthetic , including R - Ketalar , that someone may receive during an inpatient hospital halt .

After a soul pay their Part A deductible , which is$1,676 in 2025 , they may bear nothing for eligible inpatient avail for the first 60 daylight .

Medicare Part B covers R - ketamine - based anaesthetic services if someone receive it as an outpatient , such as in an parking brake room .

Once a person pays their 2025 Part B deductible of$257 , Medicare get over 80 % of eligible outpatient expense . The remaining 20 % is their coinsurance .

S-ketamine

S - ketamine hydrochloride , oresketamine ( Spravato ) , is an FDA - okay nasal consonant nebulizer that doctors and healthcare professionals may prescribe for major depressive disorderliness with suicidal ideation and treatment - resistant depressive disorder . Esketamine ( Spravato ) can be used by itself or in accession to an unwritten antidepressant drug .

Doctors and medical professionals can provide this treatment in their office through theSpravato Risk Evaluation and Mitigation Strategy ( REMS)program .

Under this program , a mortal can ego - administer the medication while a aesculapian professional supervises and monitors them for at least 2 minute to look out for any serious side burden .